Evidence map›Paper›PMID 42422007›Full record

ArticleInnovation (Cambridge (Mass.))2026

Unmasking hidden high risk in

Yang Xun, Yali Shen, Hua Yang, Jinsong Yan, Yu Tao, Yance Feng, Yi Huang, Stefan K Bohlander, Li Wei, Huihan Wang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Innovation (Cambridge (Mass.)), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Refining favorable-risk classification in pediatricBlood science (Baltimore, Md.) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yang XunPrecision Oncology and Intelligent Theranostics Laboratory, Children's Hospital of Chongqing Medical University, Chongqing, China.
Yali ShenDepartment of Pediatric Hematology and Oncology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Hua YangPrecision Oncology and Intelligent Theranostics Laboratory, Children's Hospital of Chongqing Medical University, Chongqing, China.
Jinsong YanDepartment of Hematology, The Second Hospital of Dalian Medical University, Dalian, China.
Yu TaoPrecision Oncology and Intelligent Theranostics Laboratory, Children's Hospital of Chongqing Medical University, Chongqing, China.
Yance FengPrecision Oncology and Intelligent Theranostics Laboratory, Children's Hospital of Chongqing Medical University, Chongqing, China.
Yi HuangDepartment of Cardiology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Stefan K BohlanderLeukaemia & Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
Li WeiChongqing Health Center for Women and Children, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.
Huihan WangDepartment of Hematology, Shengjing Hospital of China Medical University, Shenyang, China.
Hua YouPrecision Oncology and Intelligent Theranostics Laboratory, Children's Hospital of Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although pediatric acute myeloid leukemia (pAML) harboring the

Indexed as

immune checkpoint genesKIT mutationpediatric acute myeloid leukemiarefined risk stratificationRUNX1::RUNX1T1 fusion gene

Identifiers

PMID42422007
PMCPMC13343448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.